BioSyntech, Inc.
BSYI · OTC
12/31/2009 | 9/30/2009 | 6/30/2009 | 3/31/2009 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.31 | 0.12 | -0.09 | 0.03 |
| FCF Yield | -13.41% | -16.99% | -15.92% | -15.03% |
| EV / EBITDA | -8.46 | -7.30 | -9.12 | -5.42 |
| Quality | ||||
| ROIC | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Margin | -80.35% | 67.72% | 59.32% | 69.74% |
| Cash Conversion Ratio | 0.46 | 0.55 | 0.72 | 0.77 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.50% | -15.12% | -29.94% | -44.88% |
| Free Cash Flow Growth | 22.30% | -5.18% | 18.11% | 17.95% |
| Safety | ||||
| Net Debt / EBITDA | -4.88 | -3.91 | -4.35 | -1.88 |
| Interest Coverage | -81.28 | -89.21 | -59.75 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.03 | 1.21 | 0.36 | 0.13 |
| Cash Conversion Cycle | 319,233.83 | 1,439.52 | 2,712.96 | -4,729.84 |